{
  "ptid_time": "127_S_5028_2012-11-14",
  "img_path": "/data/qiuhui/data/adni/images/127_S_5028/2012-11-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 22,848 mm³, 23.9% below the reference mean. With a Z-score of -0.57 (28.5th percentile), this represents normal volume ; hippocampal volume measures 7,481 mm³, 6.8% below the reference mean. With a Z-score of -0.68 (24.8th percentile), this represents normal volume ; whole brain volume measures 1,182,700 mm³, 4.2% above the reference mean. With a Z-score of 0.60 (72.6th percentile), this represents normal volume ; entorhinal cortex volume measures 4,357 mm³, 2.2% above the reference mean. With a Z-score of 0.15 (56.1th percentile), this represents normal volume ; fusiform gyrus volume measures 20,829 mm³, 4.6% above the reference mean. With a Z-score of 0.38 (65.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,797 mm³, 7.2% below the reference mean. With a Z-score of -0.59 (27.6th percentile), this represents normal volume . ",
  "text_data": "Age is 61.9 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Major Surgical Procedures. MMSE: 23.0. MoCA: 19.0. Logical Memory: 3.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated); Amyloid beta: 437.60 pg/mL (moderate reduced); Total tau: 453.40 pg/mL (significant elevated); Phosphorylated tau: 49.99 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant biomarker abnormalities (elevated T-tau, P-tau, and AV45 with moderately reduced Aβ), consistent with Alzheimer's pathology. Cognitive testing (MMSE 23, MoCA 19) indicates mild impairment, but brain volumes are largely within normal ranges, suggesting early-stage neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: The cognitive scores and biomarkers strongly suggest MCI due to AD, but the preserved brain volumes indicate it may still be in the early stages before significant atrophy develops.)*",
  "timestamp": "2025-07-26T13:24:09.321175"
}